Commercialization

A practical regulatory strategy guide for medical device startups — covering FDA pathway selection, budget planning, Q-Sub pre-submissions, eSTAR templates, QMSR compliance, fundraising alignment, and the programs that accelerate market entry in 2026.

Practical guide to medical device import, customs duties, and free zone strategies across MENA — GCC Common Customs Tariff (5% standard rate), Saudi SABER/ZATCA procedures and 2026 tariff code updates, UAE EDE import requirements and free zone advantages (DHCC, DSP), Egypt EDA import approval and customs clearance, Turkey TITCK import controls, and optimization strategies for duty reduction.

How medical devices get reimbursed across MENA — Saudi Arabia CHI/NPHIES/AR-DRG value-based system, UAE mandatory insurance (Daman/Thiqa/AED 320 basic plan), Turkey SGK SUT codes and DMO procurement, Israel Health Basket, and Egypt UHIA universal insurance rollout. Market data, fees, co-payments, and market access strategies for device manufacturers.

Complete guide to medical device registration in North Africa — Morocco AMMPS/DMP (120 days, 5-year validity, 2026 local manufacturing pact), Algeria ANPP serialization framework (GS1 2D DataMatrix by 2027), and Tunisia DPM/ANMPS requirements including eCTD mandate from June 2026.

How Saudi Arabia's HSTP (290 hospitals privatized, private sector 40% to 65%, SAR 260B health budget, LCGPA 40% local content, NIDLP 40% pharma localization) and UAE's Operation 300bn (AED 300B industrial GDP target, DHCC 100% foreign ownership, EDE regulatory framework) are reshaping medical device market entry across the Gulf.

A data-driven analysis of why cardiovascular devices dominate medtech M&A — covering the Stryker/Inari, Boston Scientific/Penumbra, and Medtronic/CathWorks deals, the PFA revolution, structural heart innovation, and the forces driving CV dealmaking in 2025-2026.

A complete guide to registering medical devices in Chile through ISP (Instituto de Salud Pública). Covers the four-class risk system, GICONA registration platform, documentation requirements, fees, timelines, and the new March 2026 decree expanding mandatory registration to 39 additional device categories.

A comprehensive guide to medical device company valuation in 2025-2026 — covering EBITDA and revenue multiples by subsector, valuation methods for pre-revenue and commercial-stage companies, deal structures including earn-outs and CVRs, and the due diligence process.

A practical guide to raising venture capital for medical device startups in 2026 — covering typical raise amounts by stage, what investors evaluate, hot subsectors, the VC ecosystem, and how to position for a successful fundraise.

A complete guide to registering medical devices in Peru through DIGEMID. Covers the four-class risk system under Law 29459, VUCE electronic submission, documentation requirements by class, Peru Registration Holder obligations, fees, timelines, and practical strategies for faster market access.

A deep dive into private equity's growing role in medtech — from Blackstone and TPG's landmark $18.3B Hologic take-private to buy-and-build platforms, CDMO acquisitions, the record Medline IPO exit, and PE dry powder deployment strategies.

How to classify four common borderline products — hand sanitizer, mouthwash, personal lubricants, and data recorders — across FDA, EU MDR, Brazil ANVISA, and Mexico COFEPRIS. Includes decision trees, regulation citations, and jurisdiction-by-jurisdiction comparison tables.

Strategic analysis of dual CE Mark + FDA 510(k)/PMA approval showing the multiplier effect across 25+ markets, country grouping matrix, and concrete cost/timeline comparisons for manufacturers pursuing both pathways.

The complete guide to drug-device combination product regulation — FDA jurisdiction (OCP, RFD, 21 CFR Part 4), EU MDR Article 117, Notified Body Opinions, QMSR changes, CGMP requirements, market pathways, and post-market obligations.

How Brazil's SUS public healthcare system procures medical devices — covering the legal framework (Law 14,133/2021), CONITEC health technology assessment, e-procurement via Compras.gov.br, requirements for foreign suppliers, pricing mechanisms, and strategic recommendations for market entry.

How Germany procures and reimburses medical devices through the GKV statutory health insurance system — G-DRG case-based payments, NUB innovative device pathway, Hilfsmittelverzeichnis medical aids, DiGA digital health applications, GPO group purchasing, hospital tendering, BfArM registration, and practical strategies for foreign manufacturers entering Europe's largest medical device market.

How India procures medical devices through government channels — GeM Government e-Marketplace platform, Make in India (MII) local content requirements, CGHS and PM-JAY reimbursement schemes, HLL Medical Services procurement, CDSCO and BIS registration, tendering procedures, and practical strategies for foreign manufacturers entering India's rapidly growing medical device market.

How Indonesia procures medical devices through the e-Katalog electronic catalog system — Ministry of Health sectoral e-Katalog management, INAPROC Version 6 migration, JKN/BJPS Kesehatan national insurance reimbursement, TKDN domestic content requirements, BPOM/MoH registration, CDAKB distributor certification, and practical strategies for foreign manufacturers entering Southeast Asia's largest medical device market.

Navigate Japan's National Health Insurance system for medical devices — NHI pricing structure, STM vs. non-STM reimbursement, DPC bundling, hospital tendering, and foreign supplier requirements for the world's third-largest device market.

Transparent benchmark of medical device regulatory consulting fees across 16 countries and regions — covering hourly rates by consultant tier, factors that drive cost, and how to budget for registration projects in the US, EU, Japan, Korea, China, India, Brazil, Saudi Arabia, and more.